A citation-based method for searching scientific literature

Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip Baert, Tomas Vaňásek, Ahmet Danalioglu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J Sandborn, Paul Rutgeerts, Daniel Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Paloma Mendez, Joel Petersson, Kori Wallace, Anne M Robinson, Roopal B Thakkar, Geert D'Haens. Lancet 2017
Times Cited: 398







List of co-cited articles
807 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
L Peyrin-Biroulet, W Sandborn, B E Sands, W Reinisch, W Bemelman, R V Bryant, G D'Haens, I Dotan, M Dubinsky, B Feagan,[...]. Am J Gastroenterol 2015
981
40

Infliximab, azathioprine, or combination therapy for Crohn's disease.
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, Gerassimos J Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D'Haens, Robert H Diamond, Delma L Broussard,[...]. N Engl J Med 2010
22

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
Ryan C Ungaro, Clara Yzet, Peter Bossuyt, Filip J Baert, Thomas Vanasek, Geert R D'Haens, Vincent Wilhelmus Joustra, Remo Panaccione, Gottfried Novacek, Walter Reinisch,[...]. Gastroenterology 2020
60
31

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.
Reena Khanna, Brian Bressler, Barrett G Levesque, Guangyong Zou, Larry W Stitt, Gordon R Greenberg, Remo Panaccione, Alain Bitton, Pierre Paré, Séverine Vermeire,[...]. Lancet 2015
272
17

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D'Amico, Jasbir Dhaliwal, Anne M Griffiths, Dominik Bettenworth, William J Sandborn, Bruce E Sands, Walter Reinisch,[...]. Gastroenterology 2021
188
17

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
Marco Daperno, Geert D'Haens, Gert Van Assche, Filip Baert, Philippe Bulois, Vincent Maunoury, Raffaello Sostegni, Rodolfo Rocca, Angelo Pera, Annemie Gevers,[...]. Gastrointest Endosc 2004
881
16

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.
Christian Maaser, Andreas Sturm, Stephan R Vavricka, Torsten Kucharzik, Gionata Fiorino, Vito Annese, Emma Calabrese, Daniel C Baumgart, Dominik Bettenworth, Paula Borralho Nunes,[...]. J Crohns Colitis 2019
414
15

C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
Mahmoud H Mosli, Guangyong Zou, Sushil K Garg, Sean G Feagan, John K MacDonald, Nilesh Chande, William J Sandborn, Brian G Feagan. Am J Gastroenterol 2015
294
15

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Siew C Ng, Hai Yun Shi, Nima Hamidi, Fox E Underwood, Whitney Tang, Eric I Benchimol, Remo Panaccione, Subrata Ghosh, Justin C Y Wu, Francis K L Chan,[...]. Lancet 2017
13

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
Geert D'Haens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche,[...]. Inflamm Bowel Dis 2012
517
12

Vedolizumab as induction and maintenance therapy for Crohn's disease.
William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel, Bruce E Sands, Milan Lukas, Richard N Fedorak, Scott Lee, Brian Bressler,[...]. N Engl J Med 2013
12

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Nicholas A Kennedy, Graham A Heap, Harry D Green, Benjamin Hamilton, Claire Bewshea, Gareth J Walker, Amanda Thomas, Rachel Nice, Mandy H Perry, Sonia Bouri,[...]. Lancet Gastroenterol Hepatol 2019
225
12

Crohn's disease.
Joana Torres, Saurabh Mehandru, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet. Lancet 2017
744
12

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
795
11

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
Kathrine Frey Frøslie, Jørgen Jahnsen, Bjørn A Moum, Morten H Vatn. Gastroenterology 2007
802
10

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Filip Baert, Liesbeth Moortgat, Gert Van Assche, Philip Caenepeel, Philippe Vergauwe, Martine De Vos, Pieter Stokkers, Daniel Hommes, Paul Rutgeerts, Severine Vermeire,[...]. Gastroenterology 2010
609
10

Treat to target: a proposed new paradigm for the management of Crohn's disease.
Guillaume Bouguen, Barrett G Levesque, Brian G Feagan, Arthur Kavanaugh, Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Stephen B Hanauer, William J Sandborn. Clin Gastroenterol Hepatol 2015
182
10

Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Alain M Schoepfer, Christoph Beglinger, Alex Straumann, Michael Trummler, Stephan R Vavricka, Lukas E Bruegger, Frank Seibold. Am J Gastroenterol 2010
383
10

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
Joana Torres, Stefanos Bonovas, Glen Doherty, Torsten Kucharzik, Javier P Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager,[...]. J Crohns Colitis 2020
280
10

ACG Clinical Guideline: Management of Crohn's Disease in Adults.
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. Am J Gastroenterol 2018
454
9

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.
Benjamin Pariente, Jean-Yves Mary, Silvio Danese, Yehuda Chowers, Peter De Cruz, Geert D'Haens, Edward V Loftus, Edouard Louis, Julian Panés, Jürgen Schölmerich,[...]. Gastroenterology 2015
189
9

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
Geert D'Haens, Filip Baert, Gert van Assche, Philip Caenepeel, Philippe Vergauwe, Hans Tuynman, Martine De Vos, Sander van Deventer, Larry Stitt, Allan Donner,[...]. Lancet 2008
905
9

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
Aleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, Graham A Heap, Daniel L Rice, Mark Reppell, Claire M Bewshea, Neil Chanchlani, Gareth J Walker, Mandy H Perry,[...]. Gastroenterology 2020
115
9

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Stephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, Lloyd F Mayer, S Schreiber, Jean Frederic Colombel, Daniel Rachmilewitz, Douglas C Wolf, Allan Olson, Weihang Bao,[...]. Lancet 2002
9

Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases.
Jean-Frederic Colombel, Neeraj Narula, Laurent Peyrin-Biroulet. Gastroenterology 2017
134
9

Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.
Remo Panaccione, Subrata Ghosh, Stephen Middleton, Juan R Márquez, Boyd B Scott, Laurence Flint, Hubert J F van Hoogstraten, Annie C Chen, Hanzhe Zheng, Silvio Danese,[...]. Gastroenterology 2014
554
9

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Jean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, Robert Enns, Stephen B Hanauer, Remo Panaccione, Stefan Schreiber, Dan Byczkowski, Ju Li, Jeffrey D Kent,[...]. Gastroenterology 2007
9

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
Mark S Silverberg, Jack Satsangi, Tariq Ahmad, Ian D R Arnott, Charles N Bernstein, Steven R Brant, Renzo Caprilli, Jean-Frédéric Colombel, Christoph Gasche, Karel Geboes,[...]. Can J Gastroenterol 2005
9

Development of the Crohn's disease digestive damage score, the Lémann score.
Benjamin Pariente, Jacques Cosnes, Silvio Danese, William J Sandborn, Maïté Lewin, Joel G Fletcher, Yehuda Chowers, Geert D'Haens, Brian G Feagan, Toshifumi Hibi,[...]. Inflamm Bowel Dis 2011
383
9



Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review.
Jean-Frédéric Colombel, Geert D'haens, Wan-Ju Lee, Joel Petersson, Remo Panaccione. J Crohns Colitis 2020
75
10

Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohn's Disease.
Samuel R Fernandes, Rita V Rodrigues, Sónia Bernardo, João Cortez-Pinto, Isadora Rosa, João P da Silva, Ana R Gonçalves, Ana Valente, Cilénia Baldaia, Paula M Santos,[...]. Inflamm Bowel Dis 2017
78
10


Compliance with the faecal calprotectin test in patients with inflammatory bowel disease.
Chloé Maréchal, Isabelle Aimone-Gastin, Cédric Baumann, Bastien Dirrenberger, Jean-Louis Guéant, Laurent Peyrin-Biroulet. United European Gastroenterol J 2017
24
33

A simple index of Crohn's-disease activity.
R F Harvey, J M Bradshaw. Lancet 1980
8

Ulcerative colitis.
Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Lancet 2017
8

Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
Edouard Louis, Jean-Yves Mary, Gwenola Vernier-Massouille, Jean-Charles Grimaud, Yoram Bouhnik, David Laharie, Jean-Louis Dupas, Hélène Pillant, Laurence Picon, Michel Veyrac,[...]. Gastroenterology 2012
446
8

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu'Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger,[...]. Gut 2019
492
7

Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease.
Delphine Labaere, Annick Smismans, August Van Olmen, Paul Christiaens, Geert D'Haens, Veerle Moons, Pieter-Jan Cuyle, Johan Frans, Peter Bossuyt. United European Gastroenterol J 2014
97
7

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
Geert D'Haens, Severine Vermeire, Guy Lambrecht, Filip Baert, Peter Bossuyt, Benjamin Pariente, Anthony Buisson, Yoram Bouhnik, Jérôme Filippi, Janneke Vander Woude,[...]. Gastroenterology 2018
154
7

Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease.
Nicholas A Kennedy, Gareth-Rhys Jones, Nikolas Plevris, Rebecca Patenden, Ian D Arnott, Charlie W Lees. Clin Gastroenterol Hepatol 2019
25
28

Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
Emily K Wright, Michael A Kamm, Peter De Cruz, Amy L Hamilton, Kathryn J Ritchie, Efrosinia O Krejany, Steven Leach, Alexandra Gorelik, Danny Liew, Lani Prideaux,[...]. Gastroenterology 2015
180
7

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Bruce E Sands, Laurent Peyrin-Biroulet, Edward V Loftus, Silvio Danese, Jean-Frédéric Colombel, Murat Törüner, Laimas Jonaitis, Brihad Abhyankar, Jingjing Chen, Raquel Rogers,[...]. N Engl J Med 2019
219
7

American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
Joseph D Feuerstein, Geoffrey C Nguyen, Sonia S Kupfer, Yngve Falck-Ytter, Siddharth Singh. Gastroenterology 2017
288
7

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.
Fernando Gomollón, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James O Lindsay, Laurent Peyrin-Biroulet, Garret J Cullen, Marco Daperno, Torsten Kucharzik,[...]. J Crohns Colitis 2017
986
7

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
Laurent Peyrin-Biroulet, Walter Reinisch, Jean-Frederic Colombel, Gerassimos J Mantzaris, Asher Kornbluth, Robert Diamond, Paul Rutgeerts, Linda K Tang, Freddy J Cornillie, William J Sandborn. Gut 2014
314
7

Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.
Joana Torres, Ray K Boyapati, Nicholas A Kennedy, Edouard Louis, Jean-Frédéric Colombel, Jack Satsangi. Gastroenterology 2015
124
7

Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study.
Inger Camilla Solberg, Morten H Vatn, Ole Høie, Njaal Stray, Jostein Sauar, Jørgen Jahnsen, Bjørn Moum, Idar Lygren. Clin Gastroenterol Hepatol 2007
479
7

Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity.
Torsten Kucharzik, Bianca M Wittig, Ulf Helwig, Norbert Börner, Alexander Rössler, Stefan Rath, Christian Maaser. Clin Gastroenterol Hepatol 2017
87
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.